Sophie Rigaudeau Selected Research

Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)

6/2016

Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sophie Rigaudeau Research Topics

Disease

5	Multiple Myeloma 01/2022 - 03/2016
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 12/2008
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 02/2010
2	Blast Crisis (Blast Phase) 01/2018 - 11/2013
1	Lymphoma (Lymphomas) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Acute Promyelocytic Leukemia 12/2021
1	Thrombotic Thrombocytopenic Purpura 01/2020
1	Vomiting 01/2019
1	Lymphopenia (Lymphocytopenia) 01/2019
1	Febrile Neutropenia 01/2019
1	Philadelphia Chromosome 01/2018
1	Hodgkin Disease (Hodgkin's Disease) 04/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2017
1	Cardiotoxicity 04/2017
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 06/2016
1	Hemolysis 06/2016
1	Disease Progression 03/2016
1	Anemia 03/2016
1	Exanthema (Rash) 03/2016
1	Neutropenia 01/2016
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2014
1	Agranulocytosis (Granulocytopenia) 01/2011
1	Infections 12/2008
1	Rift Valley Fever 01/2005
1	Bunyaviridae Infections 01/2005
1	Encephalitis (Encephalitis, Rasmussen) 01/2005

Drug/Important Bio-Agent (IBA)

3	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 03/2016
3	Lenalidomide (CC 5013)FDA Link 01/2021 - 03/2016
2	carfilzomibIBA 01/2022 - 01/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 03/2016
2	Prednisone (Sone)FDA LinkGeneric 01/2019 - 03/2016
2	Azacitidine (5 Azacytidine)FDA Link 01/2018 - 11/2013
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 11/2013
2	Monoclonal AntibodiesIBA 06/2016 - 04/2014
2	Ribavirin (Virazole)FDA LinkGeneric 01/2005 - 01/2005
1	Bortezomib (Velcade)FDA Link 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021
1	Arsenic Trioxide (Trisenox)FDA Link 12/2021
1	ixazomibIBA 01/2021
1	EnzymesIBA 01/2019
1	AnthracyclinesIBA 04/2017
1	Complement System Proteins (Complement)IBA 06/2016
1	eculizumab FDA Link 06/2016
1	Thalidomide (Thalomid)FDA Link 03/2016
1	CalicheamicinsIBA 04/2014
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2014
1	Gemtuzumab (Mylotarg)FDA Link 04/2014
1	Aurora Kinase BIBA 12/2011
1	2- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA 12/2011
1	Pharmaceutical PreparationsIBA 01/2011
1	bcr-abl Fusion ProteinsIBA 02/2010
1	Imatinib Mesylate (Gleevec)FDA Link 02/2010

Therapy/Procedure

4	Therapeutics 01/2022 - 04/2017
4	Drug Therapy (Chemotherapy) 04/2017 - 12/2008
1	Transplantation 01/2022
1	Time-to-Treatment 01/2014
1	Cell Transplantation 12/2008